본문 바로가기
KERD
논문KCI 등재

2009년 한국 뇌졸중 진료지침에서 이차예방을 위한 항혈소판제 사용에 관한 내용의 부분 개정

Focused Update of 2009 Korean Clinical Practice Guidelines for the Antiplatelet Therapy in Secondary Prevention of Stroke

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류신경과학

초록

The aim of this update of Korean clinical practice guidelines for stroke is to provide timely evidence-based recommendations on the antiplatelet therapy in secondary prevention of stroke. Evidence-based recommendations are included for the use of antiplatelet agents for noncardioembolic stroke. Changes in the guidelines necessitated by new evidence will be continuously reflected in the new guideline.

Abstract

The aim of this update of Korean clinical practice guidelines for stroke is to provide timely evidence-based recommendations on the antiplatelet therapy in secondary prevention of stroke. Evidence-based recommendations are included for the use of antiplatelet agents for noncardioembolic stroke. Changes in the guidelines necessitated by new evidence will be continuously reflected in the new guideline.

참고문헌 (15)

  1. Sacco RL, "American Heart Association; American Stroke Association Council on Stroke; Council on cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association", American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline, 2006, pp.37, 577~617
  2. "European Stroke Initiative recommendations for stroke management. European Stroke Council, European Neurological Society and European Federation of Neurological Societies", Cerebrovasc Dis, 10, pp.335~351 (2000)
  3. "Assessment, investigation, immediate management and secondary prevention"[URL]
  4. "National clinical guidelines for stroke"[URL]
  5. Sacco RL, "PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke", N Engl J Med, 359, pp.1238~1251 (2008)
  6. Adams RJ, "American Heart Association; American Stroke Association. Update to the AHA", ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack, 2008, pp.39, 1647~1652
  7. Albers GW, "American College of Chest Physicians. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)", Chest, 133, pp.630S~669S (2008)
  8. "European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008", Cerebrovasc Dis, 25, pp.457~507 (2008)
  9. Collaborative overview of randomised trials of antiplatelet therapy-I, "Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists’ Collaboration", BMJ, 308, pp.81~106 (1994)
  10. "A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee", Lancet, 348, pp.1329~1339 (1996)
  11. Diener HC, "European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke", J Neurol Sci, 143, pp.1~13 (1996)
  12. ESPRIT Study Group, "Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial", Lancet, 367, pp.1665~1673 (2006)
  13. "Japanese guidelines for the management of stroke"[URL]
  14. European Stroke Initiative Executive Committee; EUSI Writing Committee, "European Stroke Initiative Recommendations for Stroke Management-update 2003", Cerebrovasc Dis, 16, pp.311~337 (2003)

관련 논문AI추천

2009년 한국 뇌졸중 진료지침에서 이차예방을 위한 항혈소판제의 사용에 관한 내용의 부분 개정권순억, 권형민, 나정호, 배희준, 오창완, 유경호, 윤병우, 이병철, 허지회, 홍근식대한신경과학회 · 대한신경과학회지2010 · 제28권 제2호뇌졸중 이차예방을 위한 항혈소판제의 사용: 2012년 한국 뇌졸중 이차예방 진료지침 부분 개정권순억, 김민기, 나정호, 박태환, 배희준, 오미선, 오창완, 오형근, 유경호, 윤병우, 이병철, 허지회, 홍근식대한뇌졸중학회 · 대한뇌졸중영문학회지2012 · 제14권 제1호2013년 한국뇌졸중진료지침 개정과 근거에 대한 고찰구자성, 김한영, 나정호, 박인성, 박종무, 박태환, 서대희, 유경호, 윤병우, 이병철, 정근화, 조경희, 홍근식대한신경과학회 · 대한신경과학회지2013 · 제31권 제3호한국뇌졸중진료지침에서 아스피린의 뇌졸중 일차예방효과에 관한 내용의 부분개정강규식, 구자성, 권순억, 김한영, 나정호, 박종무, 배희준, 오창완, 유경호, 윤병우, 이병철, 조용진, 한상원, 허지회, 홍근식대한신경과학회 · 대한신경과학회지2011 · 제29권 제4호허혈성 뇌졸중의 이차예방을 위한 항혈전제 치료강태호, 조한진대한뇌신경재활학회 · 뇌신경재활2014 · 제7권 제2호한국 뇌졸중 진료지침에서 심방세동 환자의 뇌졸중 일차예방에 관한 내용의 부분 개정강규식, 구자성, 권순억, 김한영, 나정호, 박종무, 배희준, 오창완, 유경호, 윤병우, 이병철, 조용진, 한상원, 허지회, 홍근식대한뇌졸중학회 · 대한뇌졸중영문학회지2012 · 제14권 제3호

이 간행물의 다른 논문 (6건)